CLEC4M Antibody, FITC conjugated

說明書

中文名稱：

CLEC4M兔多克隆抗體, FITC偶聯
貨號：

CSB-PA862003LC01HU
規格：

￥880
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) CLEC4M Polyclonal antibody
Uniprot No.：

Q9H2X3
基因名：

CLEC4M
別名：

C type lectin domain family 4; member M antibody; C-type lectin domain family 4 member M antibody; CD209 antigen like antibody; CD209 antigen like protein 1 antibody; CD209 antigen-like protein 1 antibody; CD209L antibody; CD209L1 antibody; CD299 antibody; CD299 antigen antibody; CLC4M_HUMAN antibody; CLEC4M antibody; DC SIGN related protein antibody; DC SIGN2 antibody; DC SIGNR antibody; DC-SIGN-related protein antibody; DC-SIGN2 antibody; DC-SIGNR antibody; DCSIGN related protein antibody; DCSIGNR antibody; Dendritic cell-specific ICAM-3-grabbing non-integrin 2 antibody; HP10347 antibody; L SIGN antibody; L-SIGN antibody; Liver/lymph node specific ICAM3 grabbing nonintegrin antibody; Liver/lymph node-specific ICAM-3-grabbing non-integrin antibody; LSIGN antibody; Mannose binding C type lectin DC SIGNR antibody; MGC129964 antibody; MGC47866 antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human C-type lectin domain family 4 member M protein (238-382AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

FITC
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產品提供形式：

Liquid
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Probable pathogen-recognition receptor involved in peripheral immune surveillance in liver. May mediate the endocytosis of pathogens which are subsequently degraded in lysosomal compartments. Is a receptor for ICAM3, probably by binding to mannose-like carbohydrates.; (Microbial infection) Acts as an attachment receptor for Ebolavirus.; (Microbial infection) Acts as an attachment receptor for Hepatitis C virus.; (Microbial infection) Acts as an attachment receptor for HIV-1.; (Microbial infection) Acts as an attachment receptor for Human coronavirus 229E.; (Microbial infection) Acts as an attachment receptor for Human cytomegalovirus/HHV-5.; (Microbial infection) Acts as an attachment receptor for Influenzavirus.; (Microbial infection) Acts as an attachment receptor for SARS-CoV.; (Microbial infection) Acts as an attachment receptor for West-nile virus.; (Microbial infection) Acts as an attachment receptor for Japanese encephalitis virus.; (Microbial infection) Acts as an attachment receptor for Marburg virus glycoprotein.; (Microbial infection) Recognition of M.bovis by dendritic cells may occur partially via this molecule.
基因功能參考文獻：
1. heterozygous VNTR genotypes 57 and 67 of CLEC4M were highly enriched and are the most likely mechanism through which CLEC4M contributes to disease in the Swedish type 1 VWD population PMID: 29389944
2. DC-SIGNR promoted gastric cancer liver metastasis mediated with HNRNPKP2 which expression was regulated by STAT5A. And HNRNPKP2 decreased the expression of downstream target gene CXCR4. These findings indicated potential therapeutic candidates for gastric cancer liver metastasis. PMID: 28403883
3. the neck domains of DC-SIGN and DC-SIGNR can contribute to the different functions of these receptors by presenting the sugar-binding sites in different contexts. PMID: 27859859
4. Together, these studies confirm a role for C-type lectin receptors DC-SIGN and L-SIGN as attachment factors and entry receptors for human metapneumovirus infection. PMID: 27334579
5. DC-SIGNR VNTR and DC-SIGN VNTR were not associated with the risk of pulmonary tuberculosis in a sample of Iranian population PMID: 27309478
6. CD209L variation may influence susceptibility to HIV-1, response to treatment, and disease progression. PMID: 25656622
7. DC-SIGNR expression in peripheral blood mononuclear cells was higher in HIV-1-infected patients, and its positive correlation with viral load and negative with CD4+ T cells counts suggest a potential role of DC-SIGNR in HIV-1 infection. PMID: 26313015
8. Study demonstrated that serum levels of DC-SIGNR in lung cancer patients were significantly lower than those in healthy individuals, and correlated significantly with brain metastasis and serum NK cells percentage. PMID: 26150177
9. Genetic variations in STXBP5 and CLEC4M are associated with VWF level variation in type 1, but not in type 2 von Willebrand disease. PMID: 25832887
10. of an association between CD209 and CD209L polymorphisms and tuberculosis development in a Brazilian population PMID: 24874302
11. DC-SIGN and DC-SIGNR are blood-based molecular markers that can potentially be used for the diagnosis of early stage patients PMID: 25504222
12. Japanese encephalitis virus infected cells through three virus receptors: DC-SIGN, DC-SIGNR and LSECtin. PMID: 24623090
13. The results indicate that neck region polymorphism of L-SIGN can influence the outcome of HCV infection and the four-tandem repeat is associated with clearance of HCV infection. PMID: 24283933
14. CLEC4M and CD81 both are still crucial for hepatitis C virus entry into hepatocytes. PMID: 24965233
15. The CLEC4M carbohydrate recognition domain rapidly and reversibly releases glycan ligands and Ca(2+) at reduced pH. PMID: 24976257
16. these results provide evidence that hDC- and hL-SIGN can mediate the entry of Junin virus into cells, and may play an important role in virus infection and dissemination in the host. PMID: 24183720
17. Up-regulation of Raf-MEK-ERK pathway by HCV E2 via L-SIGN provides new insights into signaling cascade of L-SIGN PMID: 23292357
18. Our findings suggested that DC-SIGNR neck region VNTR polymorphism was not directly associated with hosts' predisposition for HIV-1 infection and not associated with the HIV-1 routes of infection. PMID: 23602836
19. DC-SIGNR has a role in expression of lactic acid dehydrogenase and beta2-microglobulin in non-Hodgkin lymphoma PMID: 23859015
20. genetic polymorphism is associated with HIV-1 infection PMID: 23354840
21. Variable number of tandem repeats in CLEC4M is associated with type 1 von Willebrand disease. PMID: 23529928
22. Both K3 and K5 preferentially associate with DC-SIGN and DC-SIGNR, mediating their ubiquitylation and degradation. PMID: 23460925
23. Polymorphisms in DC-SIGN and L-SIGN genes are associated with HIV-1 vertical transmission in a Northeastern Brazilian population. PMID: 22902397
24. analysis of attachment factor DC-SIGNR on cells in neutralization studies failed to identify a correlation between DC-SIGNR expression and antibody-mediated protection; studies suggest cellular attachment factor expression is not a significant contributor to potency of neutralizing antibodies to flaviviruses PMID: 23312596
25. VNTR polymorphism of the DC-SIGNR gene is associated with a moderate effect on host susceptibility to HIV-1 infection, similar to CCR5 gene deletion PMID: 22957026
26. Findings do not support the hypothesis that the origin of the variable number tandem repeat (VNTR} alleles of CLEC4M were arisen by independent (separate) mutation events. PMID: 22279577
27. data demonstrate that the signaling events mediated by RSV G interactions with DC/L-SIGN are immunomodulatory and diminish DC activation, which may limit induction of RSV-specific immunity PMID: 22090124
28. There were multiple genotypes of the gene DC-SIGNR in the pregnant women infected with HBV. PMID: 22338216
29. Upon binding to membrane-anchored ligand, DC-SIGNR undergoes a conformational change similar to that previously observed for DC-SIGN. PMID: 21650186
30. Together, these data indicate that human C-type lectins (DC-SIGN and L-SIGN) can mediate attachment and entry of influenza viruses independently of cell surface sialic acid. PMID: 21191006
31. 9/5 genotype distribution frequency of DC-SIGNR's exon 4 in patients with hepatitis C is significantly higher and may be associated with HCV infection susceptibility. PMID: 18171520
32. these results suggest that the variation of the tested DC-SIGNR genotypes affects the efficacy of HIV-1 trans-infection by affecting the amounts of the protein expressed on the cell surface. PMID: 20152818
33. Our study indicated that there was absence of association between the neck region polymorphism of DC-SIGNR and longevity in Han Chinese population PMID: 20003397
34. DC-SIGNR plays a crucial role in MTCT of HIV-1 and impaired placental DC-SIGNR expression increases risk of transmission PMID: 19809496
35. DC-SIGNR was mainly expressed in the membrane and plasm in placental trophoblast cells. PMID: 20108443
36. determinants in DC-SIGN necessary for HIV-1 transmission and the differences between DC-SIGN and L-SIGN that affect HIV-1 interactions PMID: 19833723
37. Crystal structures of carbohydrate-recognition domains of DC-SIGNR bound to oligosaccharide, in combination with binding studies, reveal that it selectively recognizes endogenous high-mannose oligosaccharides PMID: 11739956
38. mediates cellular entry by Ebola virus in cis and in trans PMID: 12050398
39. reasons underlying the restricted distribution of DC-SIGNR; and expression in relation to HIV entry receptors PMID: 12152166
40. Review. This article reviews the interaction of DC-SIGN & DC-SIGNR with HIV and Ebola & discusses the mechanism of DC-SIGN-mediated viral transmission. PMID: 12223058
41. the influx or proliferation of DC-SIGN+ immature and mature DCs and L-SIGN+ cells is dynamically regulated PMID: 15111305
42. data demonstrate for the first time that lectins DC-SIGN and L-SIGN differ in their carbohydrate binding profiles PMID: 15184372
43. largely expressed on endothelial cells in liver sinusoids; results demonstrate that hepatitis C pseudoviruses captured by L-SIGN+ or DC-SIGN+ cells efficiently transinfect adjacent human liver cells PMID: 15371595
44. can serve as an alternative receptor for SARS coronavirus PMID: 15496474
45. crystal forms of truncated DC-SIGNR comprising two neck repeats and the carbohydrate-recognition domain reveal that the CRDs are flexibly linked to the neck, which contains alpha-helical segments interspersed with non-helical regions PMID: 15509576
46. crystal structure of DC-SIGNR with its last repeat region PMID: 15784257
47. DC-SIGNR, in addition to DC-SIGN, should be considered as a cofactor in sexual HIV-1 transmission; soluble isoforms, in particular, may modulate the efficiency of viral transmission and dissemination. PMID: 15812562
48. A change in the number of DC-SIGN-related (DC-SIGNR) repeats may influence its normal functions as well as its binding capacity to viral and nonviral pathogens. PMID: 16061998
49. genetic risk association study shows that individuals homozygous for CLEC4M tandem repeats are less susceptible to SARS infection. PMID: 16369534
50. Recognizes pathogens and contributes to innate immunity. PMID: 16386217
顯示更多

收起更多
亞細胞定位：

[Isoform 1]: Cell membrane; Single-pass type II membrane protein.; [Isoform 2]: Cell membrane; Single-pass type II membrane protein.; [Isoform 3]: Cell membrane; Single-pass type II membrane protein.; [Isoform 5]: Secreted.; [Isoform 6]: Secreted.; [Isoform 7]: Secreted.; [Isoform 10]: Secreted.
組織特異性：

Predominantly highly expressed in liver sinusoidal endothelial cells and in lymph node. Found in placental endothelium but not in macrophages. Expressed in type II alveolar cells and lung endothelial cells.
數據庫鏈接：

HGNC: 13523

OMIM: 605872

KEGG: hsa:10332

STRING: 9606.ENSP00000316228

UniGene: Hs.421437

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
VDAC1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human, Mouse, Rat